Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prairie Tide Diversified is a biotechnology company specializing in the discovery and commercialization of flaxseed-derived bioactive compounds, specifically a unique class of cyclic peptides known as orbitides. Founded as a spin-off from the University of Saskatchewan, the company utilizes proprietary extraction and purification technologies to isolate these molecules for use in the health, cosmetic, and food industries. Their business model combines the sale of high-value functional food ingredients, such as specialized flax oils and flours, with the long-term development of orbitides as therapeutic agents. The company's research focuses on the anti-inflammatory and antioxidant properties of these peptides, positioning them for applications in dermatology and internal medicine. Prairie Tide operates out of Saskatoon, Canada, maintaining a strong link to agricultural science and advanced molecular processing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prairie Tide Diversified.